FDA data Registry peer set 1 peer FDA shortage listed

Alternatives to cholestyramine

FDA shortage status is active for cholestyramine; 1 same-class SPL records are listed below for registry comparison only.

View cholestyramine → All alternatives

Brand: Questran

Bile Acid Sequestrant Prescription 1 alternative found

cholestyramine class peers while FDA lists an active shortage

cholestyramine (Questran) is on an FDA shortage listing while 1 other Bile Acid Sequestrant SPL records remain in this registry peer set (class inventory 2). Labeled indication field for cholestyramine: This medicine is used with a diet to lower high cholesterol, especially LDL cholesterol (the "bad" cholesterol).

Top FAERS reaction fields for cholestyramine total 6,944 reports across 10 reactions, set beside colestipol. Counts are exposure-weighted submissions, not per-patient risk.

About cholestyramine

Cholestyramine is a medicine that helps lower high cholesterol levels in your blood. It works by preventing your body from absorbing cholesterol in the intestines.

Used for: This medicine is used with a diet to lower high cholesterol, especially LDL cholesterol (the "bad" cholesterol). It may also help if you have high triglycerides, but it's not the best choice if high triglycerides are your main problem. Lowering cholesterol helps reduce your risk of heart disease.

View full cholestyramine profile →

1 Bile Acid Sequestrant peers (wide set)

colestipol

Rx

Colestid

Colestipol is used along with a healthy diet to lower high cholesterol levels, specifically LDL-C ('bad' cholesterol). It is for people who haven't been able to lower their cholesterol enough with diet alone. Lowering cholesterol can help prevent heart disease and stroke.

Compare cholestyramine vs colestipol side-by-side →

cholestyramine vs colestipol · FAERS reaction fields

FAERS top-reaction field "Diarrhoea" shows the widest count spread between cholestyramine and colestipol in this extract (1,273-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect cholestyramine colestipol
Diarrhoea 1,631 358
Fatigue 877 210
Nausea 783 221
Arthralgia 621 106
Headache 543 136
Abdominal Pain 524 87
Vomiting 503 125
Weight Decreased 498 112

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

cholestyramine shortage vs Bile Acid Sequestrant peer index

Shortage status

FDA shortage listing is active for cholestyramine (status: To Be Discontinued). Peer rows remain a registry index, not a switch guide.

Frequently Asked Questions

Does FDA list a shortage for cholestyramine while peers remain indexed? ▼
Yes - cholestyramine matched an active FDA shortage listing (To Be Discontinued) while 1 other Bile Acid Sequestrant SPL records remain in this peer index for field comparison only.

Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full cholestyramine profile →

Field note for cholestyramine: see also the generic vs brand label guide when reading Questran SPL strings.

Read our methodology - how this data is sourced, computed, and verified.